Changes in the cellular distribution of glutamine synthetase in Alzheimer's disease

Journal of Neuroscience Research

Volumn 66, Issue 5, 2001, Pages 972-980

  Robinson, Stephen R ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Astrocyte; Beta amyloid; GFAP; Glutamate; TNF

Indexed keywords

AMYLOID BETA PROTEIN; CYTOKINE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE AMMONIA LIGASE; GLUTAMIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALZHEIMER DISEASE; ASTROCYTE; BRAIN BLOOD VESSEL; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONFERENCE PAPER; ENZYME LOCALIZATION; HUMAN; HUMAN TISSUE; NERVE CELL; NEUROLOGIC DISEASE; NEUROTOXICITY; PRIORITY JOURNAL; TEMPORAL CORTEX;

AGED; ALZHEIMER DISEASE; ASTROCYTES; CAPILLARIES; CELL SIZE; CEREBRAL CORTEX; DOWN-REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE-AMMONIA LIGASE; GLUTAMIC ACID; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEURITES; NEURONS; PRESYNAPTIC TERMINALS; SENILE PLAQUES;

EID: 0035576818     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10057     Document Type: Conference Paper

References (52)

1. Inflammation and Alzheimer's disease
2. Oxidative modification of glutamine synthetase by amyloid beta peptide
3. 1H-MRS at 0.5 T
4. Glutamic acid and Alzheimer's disease
5. Amino acid concentrations in cerebrospinal fluid and plasma in Alzheimer's disease and healthy control subjects
6. Neuropatbological staging of Alzheimer-related changes
7. Functional integration of the transport of ammonium, glutamate, and glutamine in astrocytes
8. Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: Relevance to Alzheimer's disease
9. Effects of ammonia on glutamate transporter (GLAST) protein and mRNA in cultured rat cortical astrocytes
10. Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures
11. CSF excitatory amino acids and severity of illness in Alzheimer's disease
12. Glutamate uptake
13. Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia
14. Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1 + APP mouse
15. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer's disease
16. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation
17. Astrocytes glutamate producers for neurons
18. Extracellular ATP triggers tumor necrosis factor-alpha release from rat microglia
19. Brain oxidative energy and related metabolism, neuronal stress, and Alzheimer disease: A speculative synthesis
20. Possible role of ammonia in the brain in dementia of Alzheimer type
21. Ammonia is endogenously generated in the brain in the presence of presumed and verified dementia of Alzheimer type
22. Cytokine effects on glutamate uptake by human astrocytes
23. Interleukin-1 beta and tumor necrosis factor-alpha suppress dexamethasone induction of glutamine synthetase in primary mouse astrocytes
24. Neurotransmitter amino acids in cerebrospinal fluid of patients with Alzheimer's disease
25. Differential responsiveness of late passage C-6 glial cells and advanced passages of astrocytes derived from aged mouse cerebral hemispheres to cytokines and growth factors: Glutamine synthetase activity
26. The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain the role of Abetal-42
27. Glutamine synthetase (GS) expression is reduced in senile dementia of the Alzheimer type
28. Glutamine transport by the blood-brain barrier: A possible mechanism for nitrogen removal
29. The number of glutamate transporter subtype molecules at glutamatergic synapses chemical and stereological quantification in young adult rat brain
30. Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression
31. Copper, iron and zinc in Alzheimer's disease senile plaques
32. Ammonium in nervous tissue transport across cell membranes, fluxes from neurons to glial cells, and role in signalling
33. Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease
34. The inhibitory effects of beta-amyloid on glutamate and glucose uptakes by cultured astrocytes
35. beta-amyloid increases enzyme activity and protein levels of glutamine synthetase in cultured astrocytes
36. Abnormal substrate levels that depend upon mitochondrial function in cerebrospinal fluid from Alzheimer patients
37. Stability of neuronal and glial marker enzymes in post-mortem rat brain
38. Relationships between Müffler cells and neurons in a primitive tetrapod, the Australian lungfish
39. Neuronal expression of glutamine synthetase in Alzheimer's disease indicates a profound impairment of metabolic interactions with astrocytes
40. Most amyloid plaques contain ferritin-rich cells
41. Metabolic trafficking between neurons and glia
42. Cellular and regional distribution of the glutamate transporter GLAST in the CNS of rats: Nonradioactive in situ hybridization and comparative immunocytochemistry
43. Inactivation of mammalian brain glutamine synthetase by oxygen radicals
44. Glutamate and glutamine metabolism and compartmentation in astrocytes
45. Is ammonia a pathogenetic factor in Alzheimer's disease?
46. Putative amino acid transmitters in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia
47. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease
48. Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia
49. Reduction of glutamine synthetase specific activity in cultured astroglia by ferrous chloride
50. Inflammatory markers in chronic neurodegenerative disorders with emphasis on Alzheimer's disease
51. Cytokine modulation of glial glutamate uptake: A possible involvement of nitric oxide
52. Beta-secretase processing of the beta-amyloid precursor protein in transgenic mice is efficient in neurons but inefficient in astrocytes